PSMA Theranostics: A “Must Have” in Every Prostate Cancer Center. Illustration of Two Clinical Cases and Review of the Literature-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PSMA Theranostics: A “Must Have” in Every Prostate Cancer Center. Illustration of Two Clinical Cases and Review of the Literature

Published:2021-08 Issue:4 Volume:19 Page:e235-e247
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Cytawa Wojciech^ORCID,Hartrampf Philipp^ORCID,Lass Piotr,Kircher Malte^ORCID,Polat Bülent,Buck Andreas K.,Lapa Constantin

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference70 articles.

1. Clinical history of the theranostic radionuclide approach to neuroendocrine tumors and other types of cancer: historical review based on an interview of Eric P. Krenning by Rachel Levine;Levine;J Nucl Med,2017

2. Theranostics: a treasured tailor for tomorrow;Jeelani;J Pharm Bioallied Sci,2014

3. Phase 3 trial of (177)Lu-dotatate for midgut neuroendocrine tumors;Strosberg;N Engl J Med,2017

4. Current status of prostate-specific membrane antigen targeting in nuclear medicine: clinical translation of chelator containing prostate-specific membrane antigen ligands into diagnostics and therapy for prostate cancer;Kratochwil;Semin Nucl Med,2016

5. Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer;Afshar-Oromieh;Eur J Nucl Med Mol Imaging,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early biochemical and radiographic response after one cycle of [177Lu]Lu-PSMA I&T radioligand therapy in metastatic castration-resistant prostate cancer patients;European Journal of Nuclear Medicine and Molecular Imaging;2023-07-21

2. Salvage Nodal Radiotherapy as Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer Detected by Positron Emission Tomography Shows Favorable Outcome in Long-Term Follow-Up;Cancers;2022-08-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3